IgG4-related pachymeningitis

disease
On this page

Also known as idiopathic hypertrophic cranial pachymeningitisidiopathic hypertrophic craniospinal pachymeningitisidiopathic hypertrophic pachymeningitisidiopathic hypertrophic spinal pachymeningitis

Summary

IgG4-related pachymeningitis (MONDO:0018673) is a disease. A subtype of immunoglobulin G4-related sclerosing disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 39

Clinical features

Signs & symptoms

Clinical features (HPO)

39 HPO clinical features (Orphanet curated; top 39 by frequency):

HPO IDTermFrequency
HP:0002921Abnormality of the cerebrospinal fluidVery frequent (80-99%)
HP:0010652Abnormal dura mater morphologyVery frequent (80-99%)
HP:0002315HeadacheFrequent (30-79%)
HP:0002922Increased CSF protein concentrationFrequent (30-79%)
HP:0007340Lower limb muscle weaknessFrequent (30-79%)
HP:0011227Elevated circulating C-reactive protein concentrationFrequent (30-79%)
HP:0012531PainFrequent (30-79%)
HP:0032300Increased circulating IgG4 levelFrequent (30-79%)
HP:0000123NephritisOccasional (5-29%)
HP:0000246SinusitisOccasional (5-29%)
HP:0000572Visual lossOccasional (5-29%)
HP:0000587Abnormal optic nerve morphologyOccasional (5-29%)
HP:0000651DiplopiaOccasional (5-29%)
HP:0000738HallucinationsOccasional (5-29%)
HP:0001250SeizureOccasional (5-29%)
HP:0001268Mental deteriorationOccasional (5-29%)
HP:0001289ConfusionOccasional (5-29%)
HP:0001733PancreatitisOccasional (5-29%)
HP:0002015DysphagiaOccasional (5-29%)
HP:0002088Abnormal lung morphologyOccasional (5-29%)
HP:0002094DyspneaOccasional (5-29%)
HP:0002176Spinal cord compressionOccasional (5-29%)
HP:0002381AphasiaOccasional (5-29%)
HP:0002385ParaparesisOccasional (5-29%)
HP:0002840LymphadenitisOccasional (5-29%)
HP:0003319Abnormality of the cervical spineOccasional (5-29%)
HP:0003419Low back painOccasional (5-29%)
HP:0003474Somatic sensory dysfunctionOccasional (5-29%)
HP:0006824Cranial nerve paralysisOccasional (5-29%)
HP:0009744Abnormal spinal dura mater morphologyOccasional (5-29%)
HP:0009911Abnormal temporal bone morphologyOccasional (5-29%)
HP:0010558Abnormality of the clivusOccasional (5-29%)
HP:0011850ParotitisOccasional (5-29%)
HP:0030833Neck painOccasional (5-29%)
HP:0045052Abnormality of the brachial nerve plexusOccasional (5-29%)
HP:3000035Abnormality of cervical plexusOccasional (5-29%)
HP:0000929Abnormal skull morphologyVery rare (<1-4%)
HP:0001880EosinophiliaVery rare (<1-4%)
HP:0004431Complement deficiencyVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical nameIgG4-related pachymeningitis
Mondo IDMONDO:0018673
Orphanet449427
ICD-111140264879
SNOMED CT762282007
UMLSC4545992
MedGen1627405
GARD0013256
Is cancer (heuristic)no

Also known as: idiopathic hypertrophic cranial pachymeningitis · idiopathic hypertrophic craniospinal pachymeningitis · idiopathic hypertrophic pachymeningitis · idiopathic hypertrophic spinal pachymeningitis

Disease family

This is a subtype of immunoglobulin G4-related sclerosing disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › immune system disorderautoimmune diseaseimmunoglobulin G4-related sclerosing diseaseIgG4-related pachymeningitis

Related subtypes (13): autoimmune pancreatitis, IgG4-related mesenteritis, IgG4-related sclerosing cholangitis, IgG4-related kidney disease, IgG4-related aortitis, IgG4-related submandibular gland disease, IgG4-related ophthalmic disorder, eosinophilic angiocentric fibrosis, primary cutaneous plasmacytosis, cutaneous pseudolymphoma, IgG4-related retroperitoneal fibrosis, IgG4-related mediastinitis, IgG4-related thyroid disease

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.